ARTG 481085Transcranial magnetic stimulation system, mobile
ARTG ID: 481085 · BTL Medical Technologies Pty Ltd · BTL Industries Limited · Class IIa · Started February 27, 2025
Good Name: BTL Medical Technologies Pty Ltd - Transcranial magnetic stimulation system, mobile
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 481085
- Start Date
- February 27, 2025
- Effective Date
- February 27, 2025
- Country
- United Kingdom
- Address
- 161 Cleveland Way, Stevenage, Hertfordshire, SG1 6BU
The device is intended for repetitive transcranial magnetic stimulation (rTMS). The device is intended for the treatment of Major Depressive Disorder (MDD) in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication, at or above the minimal effective dose and duration in the current episode, reduction the symptoms of comorbid anxiety in patients suffering from MDD, as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD) and treatment of Binge Eating Disorder (BED).
Access comprehensive regulatory information for Transcranial magnetic stimulation system, mobile in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 481085 and sponsored by BTL Medical Technologies Pty Ltd, manufactured by BTL Industries Limited in United Kingdom. The device registration started on February 27, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.